Lab suppliers interested in learning about the laboratory sales market in Georgia may be interested to know that the University of Georgia, Athens recently received $2.9 million in life science research funding from the NIH this year for researchers to study stem cell and induced pluripotent stem cells. According to the NIH RePORTER, the project leader is Dr. Michael Pierce. The project abstract provides more information about what the life science funding will be spent studying:
“This Center is dedicated to the development of technologies and tools for the identification and characterization of glycan structures and transcripts associated with cellular glycoproteins and glycolipids. As a test-bed for the further development of glycomic technologies and tools, studies will again focus on the characterization of human pluripotent stem cells, including embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs). A range of differentiated cell lineages derived from stem cells will be incorporated into this analysis. This biological model is ideal as a test-bed for glycomics technologies and tool development because it offers a diverse range of glycan structures and challenges due to the diversity in cell types that can be generated. These studies will offer new insights into human embryonic development and will lead to the identification of new biomarkers for stem cell characterization.”
The University of Georgia, Athens receives a great deal of life science research funding on a yearly basis. In 2010, the NSF reported that total R&D expenditures in life sciences at UGA totaled $167.7 million. The NSF also gave the University of Georgia $1.2 million in research funding in 2012.
University of Georgia
Image courtesy of Wikimedia Commons
In 2012, the NIH awarded the University of Georgia $39.4 million for projects in such disciplines as biochemistry, biology, biostatistics, chemistry, microbiology, pathology and pharmacology. The NIH reported that the University of Georgia’s direct plus indirect costs in the life sciences, excluding R&D contracts and ARRA awards, totaled $34.2 million in 2011. In 2012, the NIH gave the University of Georgia $37 million in life science funding.
In 2012, the University of Georgia’s budget was $1.32 billion. The groundbreaking research being conducted by scientists at the University of Georgia also attracted a total research budget of $165.4 million in 2012. For more funding information on the University of Georgia, please read our blog articles University of Georgia Life Science Update on NIH Funding and University of Georgia Receives $3M for Bioenergy Research.
The University of Georgia is a university where researchers have a great deal of life science research funding available to keep their laboratories well stocked with lab equipment and supplies. If you are a lab supplier interested in meeting researchers or learning more about the laboratory sales market at the University of Georgia, Athens, Biotechnology Calendar, Inc. invites you to attend our annual Athens BioResearch Product Faire™ Event on February 26th, 2014. Last year, the Athens BioResearch Product Faire™ Event attracted 153 visitors. Of the attendees, 30 were purchasing agents, professors and post docs, and 29 were lab managers. The visitors came from 27 different research buildings and 28 departments across campus.
Biotechnology Calendar, Inc. is a full-service science research marketing and events-planning company that organizes life science marketing events at top research institutions across the country. If you are interested in learning about another laboratory sales market closer to home, we encourage you to view our 2013 calendar of events and 2014 calendar of events. For more information on University of Georgia life science funding statistics, or to learn more about the Athens BioResearch Product Faire™ Event, click on the button below.
